InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
+0.3%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Mann Jeffrey Z, Chief Executive Officer. Insider active across 2 companies, notably Cantel Medical CORP. Cumulatively, 9 disclosures have been recorded. Split: 1 buy · 0 sell. Total volume traded: €93k. Activity tracked since 2 June 2021. The latest transaction was filed on 4 April 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Declarations9 total
5,285 shares@ US$12.0038.2% of flowCommon StockSEC:0000947871-25-000368:0
50,803 shares0Common StockSEC:0000947871-24-000965:0
45,741 shares0Common StockSEC:0000947871-23-001113:0
4,700 shares@ US$21.6761.8% of flowCommon StockSEC:0001209191-23-045319:0
Ideal exit: 6 May 2024 (T+270)
19,674 shares0Common StockSEC:0001209191-22-058966:0
17,813 shares0Common StockSEC:0001209191-22-028635:0
16,281 shares0Common StockSEC:0001209191-22-023424:0
16,036 shares@ US$80.5950.0% of flowCommon Stock, par value $.10 per shareSEC:0001104659-21-075857:0
16,036 shares@ US$80.5950.0% of flowCommon Stock, par value $.10 per shareSEC:0001104659-21-075857
9 of 9 declarations
About Mann Jeffrey Z
Jeffrey Z. Mann is Senior Vice President and General Counsel at Cantel Medical Corp and Embecta Corp. He is responsible for legal affairs and compliance within these companies. His role involves overseeing legal and regulatory matters, ensuring that Cantel Medical and Embecta comply with applicable laws and regulations. With his expertise, he contributes to protecting the interests of the company.
